PONCE DE LEON PHARMACEUTICALS
Ponce De Leon Pharmaceuticals is a privately financed development stage company, committed to the extension of human health span, endeavoring to offer more healthy years of living. In conjunction with the Buck Institute for Research on Aging, the Company has developed a formulation comprised of GRAS (Generally Regarded As Safe) components. This formulation has been shown to radically increase mean lifespan in the invertebrate model (C. Elegan), well beyond any previously published data on drugs or compounds. Testing has now begun at the Buck Institute in the mammalian model (mouse), and the Company hopes to have a patent pending product available to the public at the conclusion of those studies, or in about three years.
PONCE DE LEON PHARMACEUTICALS
Social Links:
Industry:
Medical Medical Device Pharmaceutical
Founded:
2014-01-01
Address:
Drogheda, Louth, Ireland
Country:
Ireland
Website Url:
http://www.pdlpharma.com
Total Employee:
1+
Status:
Active
Technology used in webpage:
SPF Network Solutions DNS Network Solutions Intermedia
Similar Organizations
Metys Pharmaceuticals
Metys Pharmaceuticals is developing MP-101 to prevent and treat chemotherapy-induced peripheral neuropathy.
Osciflex
Osciflex system imitates nature’s process to prevent deadly blood clots.
Current Employees Featured
Founder
Investors List
Partisan Management Group
Partisan Management Group investment in Seed Round - Ponce De Leon Pharmaceuticals
Partisan Management Group
Partisan Management Group investment in Seed Round - Ponce De Leon Pharmaceuticals
Official Site Inspections
http://www.pdlpharma.com
- Host name: vux.netsolhost.com
- IP address: 206.188.192.218
- Location: Jacksonville United States
- Latitude: 30.1426
- Longitude: -81.5727
- Metro Code: 561
- Timezone: America/New_York
- Postal: 32258
More informations about "Ponce De Leon Pharmaceuticals"
PDL BioPharma - Wikipedia
PDL BioPharma (known as Protein Design Labs prior to 2006) is a publicly traded American holding company that since 2008 manages patents and other intellectual property that had been generated by the company. In 2008 in response to shareholder pressure, PDL spun out its active development programs to a company called Facet Biotech that it capitalized with $400 million. Protein Design Labs, founded in 1986 by cell biologist Laurence J. Korn and mathematician Car…See details»
About PDL - PDL BioPharma, Inc.
In July 2020, PDL issued its proxy statement that requested approval by its stockholders of a Plan of Dissolution as the most efficient manner of winding up the Company’s business, paying and …See details»
PDL BioPharma Inc. - AnnualReports.com
PDL BioPharma, Inc. engages in intellectual property asset management and royalty bearing assets investment activities.See details»
PDL BIOPHARMA, INC. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for PDL BIOPHARMA, INC. of Redwood City, CA. Get the latest business insights from Dun & Bradstreet.See details»
Pdl Biopharma Inc (PDLI-Q) Stock Price and News
Real-time Price Updates for Pdl Biopharma Inc (PDLI-Q), along with buy or sell indicators, analysis, charts, historical performance, news and moreSee details»
PDL BioPharma Inc Company Profile - Overview - GlobalData
PDL BioPharma Inc (PDL) formerly Protein Design Labs Inc, manages a portfolio of patents and royalty assets that include Queen et al. patents and license agreements with various …See details»
Peter Garcia | Management | PDL BioPharma, Inc.
Peter Garcia, our Vice President and Chief Financial Officer, joined the Company in May, 2013. Before joining PDL, Mr. Garcia served as CFO of BioTime, Inc., which he joined in 2011.See details»
Company PDL BioPharma, Inc. Nasdaq - MarketScreener.com
Sep 30, 2008 PDL BioPharma, Inc.: Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Nasdaq: PDLIV | NasdaqSee details»
PDL BioPharma, | PDLI Stock Price, Company Overview & News
Jun 1, 2015 PDL BioPharma, Inc. is a biotech company engaged in the management of antibody humanization patents and royalty assets, which consist of its Queen et al.See details»
PDL BioPharma - Craft
Jan 8, 2021 PDL BioPharma has 4 employees at their 1 location and $54.76 m in annual revenue in FY 2019. See insights on PDL BioPharma including office locations, competitors, …See details»
PDL Biopharma Company Profile 2024: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for PDL Biopharma. Use the PitchBook Platform to explore the full profile.See details»
Annual Reports and Proxies | PDL BioPharma, Inc.
The Investor Relations website contains information about PDL BioPharma, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
PDL BioPharma Announces Upcoming Changes to its Board of …
Dec 19, 2019 Elizabeth O'Farrell, a current independent director and the former Chief Procurement Officer at Eli Lilly and Company, has been named Chairperson of the Board, …See details»
PDL BioPharma, Inc. Investor Update Available
Nov 16, 2021 The Investor Relations website contains information about PDL BioPharma, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
PDL BioPharma Reports 2020 Third Quarter Financial Results and …
Sep 30, 2020 INCLINE VILLAGE, Nev., Nov. 11, 2020 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or "the Company") (Nasdaq: PDLI) reports financial results for the three and nine …See details»
Press Releases - PDL BioPharma, Inc.
Dec 14, 2020 INCLINE VILLAGE, Nev. , Aug. 28, 2020 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) today announced that holders of its 2.75% …See details»
PDL BioPharma Reports 2020 Second Quarter Financial Results
Jun 30, 2020 INCLINE VILLAGE, Nev., Aug. 6, 2020 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or "the Company") (Nasdaq: PDLI) reports financial results for the three and six months …See details»
Quarterly Results | PDL BioPharma, Inc.
The Investor Relations website contains information about PDL BioPharma, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
PDL BioPharma, Inc. (PDLI) Stock Price, News & Historical Data ...
Apr 24, 2017 Find the latest PDL BioPharma, Inc., PDLI stock market data. Get a full understanding of how PDL BioPharma, Inc. is performing with stock quotes and prices, as well …See details»
PDL BioPharma to Announce Third Quarter 2020 Financial Results …
Sep 30, 2020 INCLINE VILLAGE, Nev., Oct. 29, 2020 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or "the Company") (Nasdaq: PDLI) announces that it will release its third quarter 2020 …See details»